The CDC's recent update on vaccines and autism sparks confusion, raising concerns about public trust and the implications for vaccine safety.

Eylea HD offers two dosing options for patients with retinal vein occlusion: 8-week and 4-week dosing intervals.

The results of a new Kinsey Institute study show that masturbation eased menopause symptoms for a significant number of women, yet few clinicians discuss it, despite strong interest from patients.

The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced therapies and reflect new medication approvals since 2021.

Promising new medications for resistant gonorrhea, such as zoliflodacin and gepotidacin, are waiting for FDA approval, and they offer hope for effective treatment options.

Viral infections such as COVID-19, HIV and hepatitis C significantly elevate cardiovascular disease risks, highlighting the importance of vaccination and preventive strategies.

Mark Nestor reveals groundbreaking insights on botulinum toxin's evolving science, enhancing its efficacy and expanding its medical applications in dermatology.

Health benefit costs for employees are projected to rise 6.7% in 2026—the largest increase in 15 years—as employers grapple with escalating prescription drug prices, growing GLP-1 coverage and a broader push to offer diverse, cost-saving health plan options amid mounting affordability concerns.

Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.